Novel Perspectives in Genetics, Mapping and Ablation of Human VF and AF

Over the past 10 years, there has been significant research and
technological progress toward better understanding of pathophysiology,
genomic and treatment of the sudden arrhythmic death syndromes
(SADS) or Sudden Unexplained Death Syndrome (SUDS) including Brugada
syndrome, early repolarization sydrome and idiopathic ventricular
fibrillation.
Atrial fibrillation, however, continues to be a major challenge for
electrophysiologists especially after STAR AF2 clinical trial, confusion was
rampant regarding the best catheter ablation approach for treating
persistent atrial fibrillation.